Global Alzheimer's Disease Diagnostic Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: G09B62CA99ABEN
QYResearch

Abstracts

This report focuses on the global Alzheimer's Disease Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimer's Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Eli Lilly
• TauRx
• Alector
• Accera
• Treventis
• Neuro-Bio
• Cognition Therapeutics
• ...

Market segment by Type, the product can be split into

• Genetic testing
• Neurological exam
• Mini-mental state exam (MMSE)
• Brain imaging
• Other

Market segment by Application, split into

• Clinics
• Hospitals
• Diagnostic Centers
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Alzheimer's Disease Diagnostic status, future forecast, growth opportunity, key market and key players.
• To present the Alzheimer's Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Alzheimer's Disease Diagnostic are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
1.4 Market Analysis by Type
  1.4.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Genetic testing
  1.4.3 Neurological exam
  1.4.4 Mini-mental state exam (MMSE)
  1.4.5 Brain imaging
  1.4.6 Other
1.5 Market by Application
  1.5.1 Global Alzheimer's Disease Diagnostic Market Share by Application: 2020 VS 2026
  1.5.2 Clinics
  1.5.3 Hospitals
  1.5.4 Diagnostic Centers
  1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Alzheimer's Disease Diagnostic Market Perspective (2015-2026)
2.2 Alzheimer's Disease Diagnostic Growth Trends by Regions
  2.2.1 Alzheimer's Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Alzheimer's Disease Diagnostic Historic Market Share by Regions (2015-2020)
  2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Alzheimer's Disease Diagnostic Market Growth Strategy
  2.3.6 Primary Interviews with Key Alzheimer's Disease Diagnostic Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Alzheimer's Disease Diagnostic Players by Market Size
  3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2015-2020)
  3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2015-2020)
  3.1.3 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
  3.2.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2019
3.3 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
3.4 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
3.5 Date of Enter into Alzheimer's Disease Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2021-2026)

5 ALZHEIMER'S DISEASE DIAGNOSTIC BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Alzheimer's Disease Diagnostic Market Size (2015-2020)
6.2 Alzheimer's Disease Diagnostic Key Players in North America (2019-2020)
6.3 North America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
6.4 North America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Alzheimer's Disease Diagnostic Market Size (2015-2020)
7.2 Alzheimer's Disease Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
7.4 Europe Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

8 CHINA

8.1 China Alzheimer's Disease Diagnostic Market Size (2015-2020)
8.2 Alzheimer's Disease Diagnostic Key Players in China (2019-2020)
8.3 China Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
8.4 China Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Alzheimer's Disease Diagnostic Market Size (2015-2020)
9.2 Alzheimer's Disease Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
9.4 Japan Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Alzheimer's Disease Diagnostic Market Size (2015-2020)
10.2 Alzheimer's Disease Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

11 INDIA

11.1 India Alzheimer's Disease Diagnostic Market Size (2015-2020)
11.2 Alzheimer's Disease Diagnostic Key Players in India (2019-2020)
11.3 India Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
11.4 India Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Alzheimer's Disease Diagnostic Market Size (2015-2020)
12.2 Alzheimer's Disease Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Details
  13.1.2 Eli Lilly Business Overview and Its Total Revenue
  13.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
  13.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2015-2020))
  13.1.5 Eli Lilly Recent Development
13.2 TauRx
  13.2.1 TauRx Company Details
  13.2.2 TauRx Business Overview and Its Total Revenue
  13.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
  13.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  13.2.5 TauRx Recent Development
13.3 Alector
  13.3.1 Alector Company Details
  13.3.2 Alector Business Overview and Its Total Revenue
  13.3.3 Alector Alzheimer's Disease Diagnostic Introduction
  13.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  13.3.5 Alector Recent Development
13.4 Accera
  13.4.1 Accera Company Details
  13.4.2 Accera Business Overview and Its Total Revenue
  13.4.3 Accera Alzheimer's Disease Diagnostic Introduction
  13.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  13.4.5 Accera Recent Development
13.5 Treventis
  13.5.1 Treventis Company Details
  13.5.2 Treventis Business Overview and Its Total Revenue
  13.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
  13.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  13.5.5 Treventis Recent Development
13.6 Neuro-Bio
  13.6.1 Neuro-Bio Company Details
  13.6.2 Neuro-Bio Business Overview and Its Total Revenue
  13.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
  13.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  13.6.5 Neuro-Bio Recent Development
13.7 Cognition Therapeutics
  13.7.1 Cognition Therapeutics Company Details
  13.7.2 Cognition Therapeutics Business Overview and Its Total Revenue
  13.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
  13.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
  13.7.5 Cognition Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Alzheimer's Disease Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
Table 3. Ranking of Global Top Alzheimer's Disease Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Genetic testing
Table 6. Key Players of Neurological exam
Table 7. Key Players of Mini-mental state exam (MMSE)
Table 8. Key Players of Brain imaging
Table 9. Key Players of Other
Table 10. Global Alzheimer's Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Alzheimer's Disease Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Alzheimer's Disease Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Alzheimer's Disease Diagnostic Market Share by Regions (2015-2020)
Table 14. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Alzheimer's Disease Diagnostic Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Alzheimer's Disease Diagnostic Market Growth Strategy
Table 20. Main Points Interviewed from Key Alzheimer's Disease Diagnostic Players
Table 21. Global Alzheimer's Disease Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 22. Global Alzheimer's Disease Diagnostic Market Share by Players (2015-2020)
Table 23. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Diagnostic as of 2019)
Table 24. Global Alzheimer's Disease Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Alzheimer's Disease Diagnostic Product Solution and Service
Table 27. Date of Enter into Alzheimer's Disease Diagnostic Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 30. Global Alzheimer's Disease Diagnostic Market Size Share by Type (2015-2020)
Table 31. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2021-2026)
Table 32. Global Alzheimer's Disease Diagnostic Market Size Share by Application (2015-2020)
Table 33. Global Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 34. Global Alzheimer's Disease Diagnostic Market Size Share by Application (2021-2026)
Table 35. North America Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 37. North America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 38. North America Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 39. North America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 40. North America Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 41. Europe Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 43. Europe Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 45. Europe Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 47. China Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 48. China Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 49. China Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 50. China Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 51. China Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 52. China Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 53. Japan Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 55. Japan Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 57. Japan Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 61. Southeast Asia Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 63. Southeast Asia Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 65. India Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 66. India Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 67. India Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 68. India Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 69. India Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 70. India Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Alzheimer's Disease Diagnostic Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Alzheimer's Disease Diagnostic Market Share (2019-2020)
Table 73. Central & South America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Alzheimer's Disease Diagnostic Market Share by Type (2015-2020)
Table 75. Central & South America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Alzheimer's Disease Diagnostic Market Share by Application (2015-2020)
Table 77. Eli Lilly Company Details
Table 78. Eli Lilly Business Overview
Table 79. Eli Lilly Product
Table 80. Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 81. Eli Lilly Recent Development
Table 82. TauRx Company Details
Table 83. TauRx Business Overview
Table 84. TauRx Product
Table 85. TauRx Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 86. TauRx Recent Development
Table 87. Alector Company Details
Table 88. Alector Business Overview
Table 89. Alector Product
Table 90. Alector Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 91. Alector Recent Development
Table 92. Accera Company Details
Table 93. Accera Business Overview
Table 94. Accera Product
Table 95. Accera Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 96. Accera Recent Development
Table 97. Treventis Company Details
Table 98. Treventis Business Overview
Table 99. Treventis Product
Table 100. Treventis Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 101. Treventis Recent Development
Table 102. Neuro-Bio Company Details
Table 103. Neuro-Bio Business Overview
Table 104. Neuro-Bio Product
Table 105. Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 106. Neuro-Bio Recent Development
Table 107. Cognition Therapeutics Company Details
Table 108. Cognition Therapeutics Business Overview
Table 109. Cognition Therapeutics Product
Table 110. Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2015-2020) (Million US$)
Table 111. Cognition Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Alzheimer's Disease Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Genetic testing Features
Figure 3. Neurological exam Features
Figure 4. Mini-mental state exam (MMSE) Features
Figure 5. Brain imaging Features
Figure 6. Other Features
Figure 7. Global Alzheimer's Disease Diagnostic Market Share by Application: 2020 VS 2026
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Other Case Studies
Figure 12. Alzheimer's Disease Diagnostic Report Years Considered
Figure 13. Global Alzheimer's Disease Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Alzheimer's Disease Diagnostic Market Share by Regions: 2020 VS 2026
Figure 15. Global Alzheimer's Disease Diagnostic Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Alzheimer's Disease Diagnostic Market Share by Players in 2019
Figure 18. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Diagnostic as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2019
Figure 20. North America Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Alzheimer's Disease Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 29. TauRx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 31. Alector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 33. Accera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 35. Treventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 37. Neuro-Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 39. Cognition Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed